GONUL D OZAY MD
Prescription History 1538884184
Student in an Organized Health Care Education/Training Program in Washington, DC
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for GONUL D OZAY MD, an active Student in an Organized Health Care Education/Training Program specialist practicing in Washington, DC. Our medical registry currently tracks 23 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,470 documented patient claims. Among these therapy options, the most frequently utilized medication is Rytary, which accounts for 307 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other DC PrescribersVs. DC Avg |
|---|---|---|---|
| RytaryCarbidopa/Levodopa | 307 | $1,418.55 | ▲ More than typical |
About Rytary: This medication is used to treat the symptoms of Parkinson's disease (such as shakiness, stiffness, difficulty moving) or Parkinson-like conditions. Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 307 Medicare prescriptions for Rytary, about 3.1 times the volume of the typical District Of Columbia prescriber of this medication (98.6). Medicare paid an average of $1,418.55 per fill, versus $1,405.58 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 660.9 30-Day Fills standardized to 30-day supplies 19,327 Days of Medication total across all patients in 2024 | |||
| Rivastigmine | 169 | $312.41 | ▲ More than typical |
About Rivastigmine: Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Show more ▾ Rivastigmine does not cure either of these diseases, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of natural substances (neurotransmitters) in the brain. A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE. In 2024, this provider wrote 169 Medicare prescriptions for Rivastigmine, about 3.2 times the volume of the typical District Of Columbia prescriber of this medication (53.1). Medicare paid an average of $312.41 per fill, versus $275.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 402 30-Day Fills standardized to 30-day supplies 12,060 Days of Medication total across all patients in 2024 | |||
| Rasagiline Mesylate | 151 | $233.42 | ▲ More than typical |
About Rasagiline Mesylate: Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. Show more ▾ It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Rasagiline belongs to a class of drugs known as MAO inhibitors. It works by increasing the levels of certain natural substances in the brain (such as dopamine, norepinephrine, serotonin). Parkinson's disease is thought to be caused by too little dopamine in the brain. Monoamine oxidase type-B inhibitor that is not metabolized to amphetamine derivatives; can lead to fatal hypertensive crisis in patients who consume tyramine-rich foods. In 2024, this provider wrote 151 Medicare prescriptions for Rasagiline Mesylate, about 1.9 times the volume of the typical District Of Columbia prescriber of this medication (79.8). Medicare paid an average of $233.42 per fill, versus $191.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 411 30-Day Fills standardized to 30-day supplies 12,310 Days of Medication total across all patients in 2024 | |||
| NuplazidPimavanserin Tartrate | 142 | $7,343.47 | ▲ More than typical |
About Nuplazid: This medication is used to treat the symptoms of a certain mental/mood disorder (psychosis) that might occur with Parkinson's disease. Show more ▾ Pimavanserin belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. A 5-HT(2A) inverse agonist. It is used to treat hallucinations and delusions associated with PARKINSON DISEASE. In 2024, this provider wrote 142 Medicare prescriptions for Nuplazid, about 2.2 times the volume of the typical District Of Columbia prescriber of this medication (65.8). Medicare paid an average of $7,343.47 per fill, versus $7,055.40 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 195 30-Day Fills standardized to 30-day supplies 5,846 Days of Medication total across all patients in 2024 | |||
| NourianzIstradefylline | 129 | $3,156.51▼ below DC avg | ▲ More than typical |
About Nourianz: Istradefylline is used by people with Parkinson's disease taking carbidopa/levodopa to reduce the amount of "off" time (periods of slow movement or stiffness). In 2024, this provider wrote 129 Medicare prescriptions for Nourianz, about 2.3 times the volume of the typical District Of Columbia prescriber of this medication (56.1). Medicare paid an average of $3,156.51 per fill, versus $3,319.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 221 30-Day Fills standardized to 30-day supplies 6,628 Days of Medication total across all patients in 2024 | |||
| Escitalopram Oxalate | 84 | $21.56 | ▲ More than typical |
About Escitalopram Oxalate: This medication is used to treat certain mental/mood disorders (such as depression, anxiety). Show more ▾ Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2024, this provider wrote 84 Medicare prescriptions for Escitalopram Oxalate, about 2.6 times the volume of the typical District Of Columbia prescriber of this medication (32.6). Medicare paid an average of $21.56 per fill, versus $14.22 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 229.3 30-Day Fills standardized to 30-day supplies 6,855 Days of Medication total across all patients in 2024 | |||
| Carbidopa-LevodopaCarbidopa/Levodopa | 82 | $32.38 | ≈ Typical |
About Carbidopa-Levodopa: This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 82 Medicare prescriptions for Carbidopa-Levodopa, about the same volume as the typical District Of Columbia prescriber of this medication (71.9). Medicare paid an average of $32.38 per fill, versus $30.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 205.5 30-Day Fills standardized to 30-day supplies 6,108 Days of Medication total across all patients in 2024 | |||
| Donepezil Hcl | 64 | $18.00 | ▲ More than typical |
About Donepezil Hcl: Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain. An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE. In 2024, this provider wrote 64 Medicare prescriptions for Donepezil Hcl, about 1.4 times the volume of the typical District Of Columbia prescriber of this medication (46.9). Medicare paid an average of $18.00 per fill, versus $14.33 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 184 30-Day Fills standardized to 30-day supplies 5,475 Days of Medication total across all patients in 2024 | |||
| GocovriAmantadine Hcl | 52 | $5,262.68 | ▲ More than typical |
About Gocovri: This medication is used to treat Parkinson's disease. Show more ▾ It is also used to treat certain movement disorders caused by some drugs (extrapyramidal reactions). This medication is thought to work by restoring the balance of certain natural substances (neurotransmitters) in the brain. Different brands of this medication may have different uses. Do not change brands of this medication unless directed by your doctor. An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. In 2024, this provider wrote 52 Medicare prescriptions for Gocovri, about 1.5 times the volume of the typical District Of Columbia prescriber of this medication (33.7). Medicare paid an average of $5,262.68 per fill, versus $4,401.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 96 30-Day Fills standardized to 30-day supplies 2,880 Days of Medication total across all patients in 2024 | |||
| Memantine Hcl | 48 | $65.57 | ≈ Typical |
About Memantine Hcl: Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease. AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent. In 2024, this provider wrote 48 Medicare prescriptions for Memantine Hcl, about the same volume as the typical District Of Columbia prescriber of this medication (46.7). Medicare paid an average of $65.57 per fill, versus $34.85 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 97.5 30-Day Fills standardized to 30-day supplies 2,880 Days of Medication total across all patients in 2024 | |||
| Droxidopa | 35 | $1,867.95▼ below DC avg | ≈ Typical |
About Droxidopa: Droxidopa is used to treat symptoms of low blood pressure when standing, caused by a certain medical condition (neurogenic orthostatic hypotension-NOH). Show more ▾ This medication can lessen symptoms of low blood pressure when standing (orthostatic hypotension), such as dizziness, lightheadedness, or the "feeling that you are about to black out." Droxidopa is used by people whose daily activities are severely affected by this condition, even after other treatments are used (such as support stockings, water bolus). It is thought to work by making the blood vessels become more narrow, which increases blood pressure. A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION. In 2024, this provider wrote 35 Medicare prescriptions for Droxidopa, about the same volume as the typical District Of Columbia prescriber of this medication (34.2). Medicare paid an average of $1,867.95 per fill, versus $3,302.06 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 72.2 30-Day Fills standardized to 30-day supplies 2,165 Days of Medication total across all patients in 2024 | |||
| Fludrocortisone Acetate | 32 | $24.09▼ below DC avg | ▲ More than typical |
About Fludrocortisone Acetate: Fludrocortisone is a man-made form of a natural substance (glucocorticoid) made by the body. Show more ▾ It is used along with other medications (such as hydrocortisone) to treat low glucocorticoid levels caused by disease of the adrenal gland (such as Addison's disease, adrenocortical insufficiency, salt-losing adrenogenital syndrome). Glucocorticoids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal. They are also needed to break down carbohydrates in your diet. A synthetic mineralocorticoid with anti-inflammatory activity. In 2024, this provider wrote 32 Medicare prescriptions for Fludrocortisone Acetate, about 2 times the volume of the typical District Of Columbia prescriber of this medication (16.4). Medicare paid an average of $24.09 per fill, versus $24.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 70 30-Day Fills standardized to 30-day supplies 2,100 Days of Medication total across all patients in 2024 | |||
| Quetiapine Fumarate | 28 | $5.00▼ below DC avg | ▼ Less than typical |
About Quetiapine Fumarate: This medication is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder). Show more ▾ Quetiapine belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER. In 2024, this provider wrote 28 Medicare prescriptions for Quetiapine Fumarate, about 61% of the volume of the typical District Of Columbia prescriber of this medication (46.2). Medicare paid an average of $5.00 per fill, versus $17.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 58 30-Day Fills standardized to 30-day supplies 1,730 Days of Medication total across all patients in 2024 | |||
| Pyridostigmine Bromide | 20 | $45.96▼ below DC avg | ≈ Typical |
About Pyridostigmine Bromide: Pyridostigmine is used to improve muscle strength in patients with a certain muscle disease (myasthenia gravis). Show more ▾ It works by preventing the breakdown of a certain natural substance (acetylcholine) in your body. Acetylcholine is needed for normal muscle function. A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. In 2024, this provider wrote 20 Medicare prescriptions for Pyridostigmine Bromide, about 82% of the volume of the typical District Of Columbia prescriber of this medication (24.4). Medicare paid an average of $45.96 per fill, versus $77.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 36.6 30-Day Fills standardized to 30-day supplies 1,098 Days of Medication total across all patients in 2024 | |||
| Midodrine Hcl | 19 | $78.38 | ▼ Less than typical |
About Midodrine Hcl: This medication is used for certain patients who have symptoms of low blood pressure when standing. Show more ▾ This condition is also known as orthostatic hypotension. Midodrine is used in people whose daily activities are severely affected by this condition, even after other treatments are used (such as support stockings). It is known as a sympathomimetic (alpha receptor agonist) that acts on the blood vessels to raise blood pressure. An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION. In 2024, this provider wrote 19 Medicare prescriptions for Midodrine Hcl, about 65% of the volume of the typical District Of Columbia prescriber of this medication (29.2). Medicare paid an average of $78.38 per fill, versus $55.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45 30-Day Fills standardized to 30-day supplies 1,329 Days of Medication total across all patients in 2024 | |||
| Duloxetine Hcl | 19 | $33.75 | ▼ Less than typical |
About Duloxetine Hcl: This medication is used to treat certain mental/mood disorders (such as depression, anxiety). Show more ▾ It is also used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA. In 2024, this provider wrote 19 Medicare prescriptions for Duloxetine Hcl, about half the volume of the typical District Of Columbia prescriber of this medication (32.5). Medicare paid an average of $33.75 per fill, versus $26.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57 30-Day Fills standardized to 30-day supplies 1,710 Days of Medication total across all patients in 2024 | |||
| Memantine Hcl ErMemantine Hcl | 17 | $240.24 | ▼ Less than typical |
About Memantine Hcl Er: Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease. AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent. In 2024, this provider wrote 17 Medicare prescriptions for Memantine Hcl Er, about half the volume of the typical District Of Columbia prescriber of this medication (30.4). Medicare paid an average of $240.24 per fill, versus $144.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 46.5 30-Day Fills standardized to 30-day supplies 1,394 Days of Medication total across all patients in 2024 | |||
| InbrijaLevodopa | 13 | $3,747.38 | ▼ Less than typical |
About Inbrija: This medication is used when needed to treat the return of Parkinson's symptoms (known as OFF episodes) in people with Parkinson's disease who are treated with carbidopa/levodopa medicines. Show more ▾ Parkinson's disease tends to worsen over time, and you may need extra levodopa from time to time to keep symptoms (such as shakiness, stiffness, difficulty moving) from returning. This medication does not replace your regular carbidopa/levodopa medicine. Keep taking your carbidopa/levodopa medicine regularly as directed by your doctor. Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. In 2024, this provider wrote 13 Medicare prescriptions for Inbrija, about 61% of the volume of the typical District Of Columbia prescriber of this medication (21.3). Medicare paid an average of $3,747.38 per fill, versus $3,284.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.5 30-Day Fills standardized to 30-day supplies 332 Days of Medication total across all patients in 2024 | |||
| Propranolol Hcl | 12 | $7.80▼ below DC avg | ▼ Less than typical |
About Propranolol Hcl: This medication is a beta blocker used to treat high blood pressure, irregular heartbeats, shaking (tremors), and other conditions. Show more ▾ It is used after a heart attack to improve the chance of survival. It is also used to prevent migraine headaches and chest pain (angina). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Preventing chest pain can help improve your ability to exercise. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This effect reduces heart rate, blood pressure, and strain on the heart. A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. In 2024, this provider wrote 12 Medicare prescriptions for Propranolol Hcl, about 64% of the volume of the typical District Of Columbia prescriber of this medication (18.7). Medicare paid an average of $7.80 per fill, versus $17.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 22.7 30-Day Fills standardized to 30-day supplies 680 Days of Medication total across all patients in 2024 | |||
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 12 | $217.95▼ below DC avg | ▼ Less than typical |
About Carbidopa-Levodopa-Entacapone: This combination medication is used to treat symptoms of Parkinson's disease (such as shakiness, stiffness, difficulty moving). Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa and entacapone prevent the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 12 Medicare prescriptions for Carbidopa-Levodopa-Entacapone, about a quarter of the volume of the typical District Of Columbia prescriber of this medication (42.9). Medicare paid an average of $217.95 per fill, versus $369.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2024 | |||
| Ropinirole ErRopinirole Hcl | 12 | $149.55 | – No State Data |
About Ropinirole Er: This medication is used alone or with other medications to treat Parkinson's disease. Show more ▾ It can improve your ability to move and decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move ("on-off syndrome"). Ropinirole works by helping to restore the balance of a certain natural substance (dopamine) in the brain. In 2024, this provider wrote 12 Medicare prescriptions for Ropinirole Er. Medicare paid an average of $149.55 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $149.55 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 878 Days of Medication total across all patients in 2024 | |||
| Austedo XrDeutetrabenazine | 12 | $5,603.03▼ below DC avg | ▼ Less than typical |
About Austedo Xr: Deutetrabenazine is used to decrease involuntary movements (chorea) caused by Huntington's disease. Show more ▾ It is also used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). Reducing involuntary movements will help you take part in more of your normal daily activities. This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine). A vesicular monoamine transporter type 2 inhibitor. In 2024, this provider wrote 12 Medicare prescriptions for Austedo Xr, about half the volume of the typical District Of Columbia prescriber of this medication (22). Medicare paid an average of $5,603.03 per fill, versus $7,193.30 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Ipratropium Bromide | 11 | $24.99▼ below DC avg | ▼ Less than typical |
About Ipratropium Bromide: Ipratropium is used to treat a runny nose caused by the common cold or seasonal allergies. Show more ▾ It works by reducing the amount of fluid/mucus released from inside your nose. This medication does not relieve symptoms of stuffy nose or sneezing. A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. In 2024, this provider wrote 11 Medicare prescriptions for Ipratropium Bromide, about a third of the volume of the typical District Of Columbia prescriber of this medication (26.4). Medicare paid an average of $24.99 per fill, versus $31.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 12.9 30-Day Fills standardized to 30-day supplies 301 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for GONUL D OZAY MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Student in an Organized Health Care Education/Training Program prescribing approach at this Washington, DC practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among DC prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
